1. FBXO7, a tumor suppressor in endometrial carcinoma, suppresses INF2-associated mitochondrial division
    Hui Zhang et al, 2023, Cell Death & Disease CrossRef
  2. Kelch-like protein 3 in human disease and therapy
    Yan Lin et al, 2022, Molecular Biology Reports CrossRef
  3. Roles of NOLC1 in cancers and viral infection
    Fengguang Zhai et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  4. Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis
    Tatsuya Katsumi et al, 2024, The Journal of Dermatology CrossRef
  5. Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways
    Gabriele Bonetti et al, 2022, International Journal of Molecular Sciences CrossRef
  6. From driver genes to gene families: A computational analysis of oncogenic mutations and ubiquitination anomalies in hepatocellular carcinoma
    Meng Wang et al, 2024, Computational Biology and Chemistry CrossRef
  7. LZTR1Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
    Aram Ko et al, 2023, Cancer Discovery CrossRef
  8. Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment
    Meng Wang et al, 2024, PLOS Computational Biology CrossRef
  9. SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics
    Yuqun Hong et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
  10. Siah1 in cancer and nervous system diseases (Review)
    Hui Zhang et al, 2021, Oncology Reports CrossRef
  11. The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination
    Fengguang Zhai et al, 2022, Gene CrossRef
  12. Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients
    Sergey G. Shcherbak et al, 2022, Genes CrossRef
  13. Biallelic LZTR1 variants in a 49‐year‐old woman with hypertrophic cardiomyopathy: A clue for considering LZTR1 in adults
    Giuseppe Di Stolfo et al, 2024, American Journal of Medical Genetics Part A CrossRef
  14. Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm
    Koichiro Fukuchi et al, 2023, International Journal of Hematology CrossRef
  15. Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review)
    Yan Lin et al, 2023, Experimental and Therapeutic Medicine CrossRef
  16. Low protein expression of LZTR1 in hepatocellular carcinoma triggers tumorigenesis via activating the RAS/RAF/MEK/ERK signaling
    Ganghui Ye et al, 2024, Heliyon CrossRef
  17. A rare case of Noonan syndrome associated with biallelic variants in the LZTR1
    Leila A. Gandaeva et al, 2023, L.O. Badalyan Neurological Journal CrossRef